Celanese Corp (CE)

Insider Trading Filed: 2026-05-13

Key Insights

Director Bruce E. Chinn acquired 2,975 restricted stock units (RSUs) on 05/11/2026 as part of an annual grant under the company's incentive plan, with no purchase price, indicating standard executive compensation rather than discretionary buying.
The RSUs vest in full after one year, demonstrating typical director/executive retention structures; this is a routine compensation action rather than a signal of insider confidence in the stock's near-term performance.
Chinn's total beneficial ownership following this transaction is 7,261 shares, representing a modest position that suggests limited personal financial exposure relative to typical insider accumulation patterns.

Insider Trading Filed: 2026-05-13

Key Insights

Anne P. Noonan, a Board Director at Celanese Corp, received an annual grant of 2,975 restricted stock units (RSUs) on May 11, 2026, vesting in one year, indicating routine director compensation rather than discretionary insider buying.
The transaction represents equity compensation at no cost ($0 price), which is standard for director RSU grants and does not signal insider confidence about stock valuation or future performance.
This filing shows Noonan now beneficially owns 2,975 shares directly following the grant, but the modest size and non-discretionary nature of this transaction provides minimal insight into management's conviction about the company's prospects.

Insider Trading Filed: 2026-05-13

Key Insights

Director Michael Koenig acquired 2,975 restricted stock units (RSUs) on 05/11/2026 as part of an annual grant under the company's 2018 Global Incentive Plan, vesting over one year, indicating standard executive compensation practices.
Koenig sold 1,013 shares on 05/09/2026 at $57.51 per share through a tax withholding transaction related to RSU vesting, a routine administrative event rather than a discretionary market sale.
Total beneficial ownership increased to 8,320 shares following these transactions, reflecting net accumulation of equity despite the tax withholding sale, suggesting modest confidence in the company's direction.
The filing shows no material insider selling pressure or significant changes in Koenig's ownership position relative to the company's size, representing routine equity compensation activity typical for directors.

Insider Trading Filed: 2026-05-13

Key Insights

Director Ganesh Moorthy received 2,975 restricted stock units (RSUs) as an annual grant on 05/11/2026, vesting in one year, representing routine equity compensation rather than discretionary insider buying.
Total beneficial ownership increased to 8,990 shares directly held plus 3,000 shares indirectly through the Ganesh and Hema Moorthy Revocable Living Trust, indicating established long-term stake in the company.
The $0 transaction price reflects a compensation grant rather than open-market purchase, providing no signal about insider confidence regarding current stock valuation or future prospects.

Insider Trading Filed: 2026-05-13

Key Insights

Director Deborah J. Kissire received 2,975 restricted stock units (RSUs) as an annual grant on 05/11/2026, vesting in one year, indicating continued equity compensation for board service.
Kissire deferred 3,376 vested shares into phantom stock under the 2008 Deferred Compensation Plan rather than taking physical shares, suggesting a tax optimization strategy and confidence in long-term company value.
Total beneficial ownership increased modestly to 4,075 direct shares plus 9,303.777 phantom shares, representing a relatively small equity stake for a director-level insider with no material selling activity detected.
The phantom stock position accrued dividend equivalents (2.984 shares at $59.55), demonstrating the deferral account is generating returns consistent with common stock performance.

Insider Trading Filed: 2026-05-13

Key Insights

Director Kim K.W. Rucker executed a vesting of 3,376 RSUs on 05/09/2026 and immediately deferred receipt into phantom stock under the company's deferred compensation plan, indicating a preference to defer compensation rather than take immediate equity.
Rucker received an annual grant of 2,975 RSUs on 05/11/2026 with a one-year vesting schedule, with the director having pre-elected to defer these shares into phantom stock upon vesting, showing consistent deferral strategy.
Total phantom stock position increased to 12,900.519 shares following dividend equivalent accruals of 4.796 shares at $59.55, demonstrating accumulation of deferred compensation benefits tied to company stock performance.
The deferral strategy and continued equity accumulation suggest director confidence in the company's long-term prospects, though the use of phantom stock (rather than direct stock ownership) may indicate timing flexibility for liquidity decisions.

Insider Trading Filed: 2026-05-13

Key Insights

Director Kathryn Hill acquired 2,975 restricted stock units (RSUs) on 05/11/2026 as an annual grant with a $0 price, vesting in one year, indicating standard equity compensation practices for board members.
Hill also received 0.575 phantom stock shares valued at $59.55 as dividend equivalents on deferred compensation, demonstrating accumulation of equity positions through the company's deferred compensation plan.
Post-transaction, Hill's total beneficial ownership stands at 19,783.48 common shares directly held plus 1,141.769 phantom stock shares, reflecting substantial personal investment alignment with shareholder interests.
The routine nature of these transactions (annual RSU grant and dividend equivalents) with no selling activity suggests insider confidence and continued commitment to the company by a board member.

Insider Trading Filed: 2026-05-13

Key Insights

Director Christopher J. Kuehn received 2,975 RSUs as an annual grant on 05/11/2026, vesting in one year, indicating continued compensation alignment with company performance.
Kuehn deferred 3,376 vested shares into phantom stock under the 2008 Deferred Compensation Plan rather than taking direct ownership, suggesting confidence in long-term company prospects and tax planning strategy.
The transactions show routine equity compensation activity with no direct open market purchases, indicating no significant insider confidence signal through discretionary buying.
Total phantom stock position of 3,376 shares represents deferred compensation with no price disclosure, limiting assessment of actual economic value at transaction time.

Insider Trading Filed: 2026-05-13

Key Insights

Director Edward G. Galante acquired 4,676 shares of restricted stock units (RSUs) on 05/11/2026 as an annual grant under the company's incentive plan, with full vesting in one year, indicating routine director compensation.
Galante also received 3.429 shares of phantom stock representing dividend equivalents on deferred compensation, payable upon termination of service, demonstrating the company's use of deferred compensation arrangements for directors.
Total beneficial ownership increased to 26,053 shares of common stock following the transaction, suggesting continued confidence in the company by board-level insiders, though the acquisition was compensation-based rather than market-driven buying.

Quarterly Report Filed: 2026-05-06

Key Insights

The filing shows extensive debt structure with multiple tranches of senior unsecured notes maturing between 2026-2034 across USD and EUR denominations, indicating active debt management and refinancing activity requiring close monitoring.
The presence of the Micromax disposal transaction (completed 2/2/2026) and Lanaken Belgium acetyl chain operations suggests ongoing portfolio optimization and potential restructuring efforts to focus on core competencies.
The filing references both Engineered Materials and Acetyl Chain segments with detailed intangible asset tracking (licensing agreements, customer relationships, developed technology rights), indicating significant acquisition-related amortization and goodwill considerations affecting earnings quality.
Multi-currency exposure across CNY, EUR, and JPY with foreign currency transaction gains/losses recorded demonstrates material foreign exchange risk that could impact reported earnings volatility going forward.

Current Report Filed: 2026-05-05

Key Insights

Celanese is hosting a Q1 2026 earnings presentation on May 6, 2026, indicating the company is actively communicating financial results to investors and analysts, which is routine quarterly disclosure.
The filing references multiple non-GAAP financial measures with reconciliations to GAAP measures, suggesting management may be highlighting adjusted metrics that differ from standard accounting results, requiring investor scrutiny of the reconciliations.
The company maintains a diverse debt structure with senior unsecured notes maturing between 2026-2031, with the 2026 notes approaching maturity within days of this filing, indicating active debt management and refinancing considerations.

Current Report Filed: 2026-05-05

Key Insights

Celanese reported Q1 2026 financial results on May 5, 2026, with earnings announcement made via press release; the filing structure indicates routine quarterly earnings disclosure rather than an extraordinary event.
Company maintains multiple debt instruments across various maturity dates (2026-2031) with EUR-denominated senior unsecured notes, suggesting active debt management and refinancing activities typical for a large chemical manufacturer.
Non-US GAAP reconciliations are provided alongside reported results, indicating management is highlighting adjusted metrics that may differ materially from GAAP figures—investors should carefully review the reconciliation details in Exhibit 99.2 to understand earnings quality.

Current Report Filed: 2026-04-17

Key Insights

Celanese Corporation held its 2026 Annual Meeting of Shareholders, with a quorum of 88.53% of outstanding shares voting.
Shareholders approved the election of the nine director nominees, the ratification of KPMG LLP as the company's independent auditor for 2026, and the advisory vote on executive compensation.
The filing does not indicate any major changes or events, suggesting this was a routine annual shareholder meeting.

Insider Trading Filed: 2026-03-11

Key Insights

Edward G. Galante, a director at Celanese Corp, acquired 4.028 shares of the company's phantom stock on March 10, 2026, suggesting he is accumulating equity in the company.
The phantom stock acquired by Galante represents dividend equivalents on compensation deferred under the company's 2008 Deferred Compensation Plan, indicating he is participating in the company's long-term compensation programs.
This transaction represents a relatively small amount of shares, but it could signal Galante's confidence in Celanese's future performance and his alignment with shareholder interests.

Insider Trading Filed: 2026-03-11

Key Insights

Deborah J. Kissire, a director at Celanese Corp, acquired 3.505 shares of phantom stock representing the right to receive 3.505 shares of common stock. This indicates an increase in the director's economic stake in the company.
The acquisition of phantom stock was through dividend equivalents on compensation deferred under the company's 2008 Deferred Compensation Plan, suggesting the director is participating in the company's long-term incentive program.
While the transaction size is relatively small, insider buying can be viewed positively as it suggests the director's confidence in the company's outlook.

Insider Trading Filed: 2026-03-11

Key Insights

Kathryn Hill, a director of Celanese Corporation, acquired 0.675 shares of Celanese common stock in the form of phantom stock under the company's deferred compensation plan.
The transaction on March 10, 2026 represents a small accumulation of Celanese shares by an insider, which could signal management's confidence in the company's outlook.
This filing is a routine disclosure of an insider transaction and does not indicate any significant changes to Celanese's business or financial condition.

Current Report Filed: 2026-03-04

Key Insights

Celanese Corporation announced the resignation of Timothy Go from the Board of Directors, effective February 27, 2026. The resignation is not due to any disagreement with the company's operations, policies, or practices.
The company's stock is traded on the New York Stock Exchange, with various senior notes also listed, including 4.777% Senior Notes due 2026, 2.125% Senior Notes due 2027, 0.625% Senior Notes due 2028, 5.337% Senior Notes due 2029, and 5.000% Senior Notes due 2031.
The filing does not provide any additional details or context around the director's resignation, which appears to be a routine event without any underlying issues.

Insider Trading Filed: 2026-03-03

Key Insights

The CEO and President, Scott A. Richardson, acquired 50,623 shares of Celanese Corp's common stock, indicating strong insider confidence in the company.
Richardson also received 70,663 stock options with a strike price of $49.09, further aligning his interests with shareholders.
The restricted stock units (RSUs) granted to Richardson will vest over the next 3 years, incentivizing him to drive long-term value creation.

Insider Trading Filed: 2026-03-03

Key Insights

The reporting person, Mark Christopher Murray, is an SVP of the Acetyls division at Celanese Corp, indicating his seniority and involvement in the company's operations.
Murray acquired 10,431 shares of Celanese's common stock through a time-based restricted stock unit (RSU) grant, suggesting further alignment of his interests with shareholders.
Murray was also granted 14,561 non-qualified stock options, vesting over 3 years, incentivizing him to drive long-term value creation for the company.

Insider Trading Filed: 2026-03-03

Key Insights

The reporting person, Aaron M. McGilvray, acquired 1,687 shares of Celanese Corp (CE) common stock through time-based restricted stock units, indicating increased personal investment in the company.
McGilvray also received 2,355 nonqualified stock options with an exercise price of $49.09, further aligning his compensation with company performance.
The insider transactions suggest continued confidence in Celanese's long-term prospects, as the restricted stock units and options vest over several years.

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Important Information